Geftib Gefitinib – 250 mg (1 pack / 30 tablets)

Buy Geftib 250 mg Gefitinib Tablets Online

Geftib Gefitinib – 250 mg (1 pack / 30 tablets)

At a Glance

Generic Name: Gefitinib

Brand Name: Geftib

Strength & Pack Size: Geftib 250 mg tablets – 1 pack / 30 tablets

Dosage Form: Oral film-coated tablets

Therapeutic Class: EGFR tyrosine kinase inhibitor, targeted anticancer therapy

Main Indication: Advanced or metastatic non-small cell lung cancer (NSCLC) with sensitising EGFR mutations as indicated

Use in Therapy: First-line or subsequent-line targeted treatment under specialist oncology guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from light and moisture

Product Description

Geftib 250 mg is a generic gefitinib tablet used as targeted therapy in selected patients with advanced or metastatic
non-small cell lung cancer (NSCLC). Many NSCLC tumours, particularly adenocarcinomas, carry activating EGFR mutations that make tumour cells
highly dependent on EGFR signalling. Geftib gefitinib 250 mg tablets are designed to inhibit this pathway, helping to slow disease progression in
EGFR mutation–positive lung cancer under the care of an experienced oncology team.

Each Geftib tablet contains 250 mg gefitinib, the standard oral dose used in most gefitinib treatment protocols.
The 1 pack / 30 tablets presentation provides approximately one month of once-daily therapy for many patients, making it easy to synchronise
Geftib orders with monthly visits and imaging. As a generic gefitinib 250 mg product, Geftib offers the same active ingredient and strength as originator gefitinib
while often being more accessible in USD, which is important for long-term targeted therapy.

Geftib 250 mg gefitinib tablets are typically used in patients with advanced or metastatic NSCLC whose tumours have been confirmed to carry sensitising EGFR mutations.
In some settings, Geftib gefitinib is prescribed as first-line therapy; in others, it is used after prior systemic treatment, depending on local guidelines.
Generic Meds Mart does not design treatment; we supply Geftib 250 mg in the pack size and quantity your oncologist specifies.

Key Uses

Geftib 250 mg gefitinib tablets are generally used for the following indications under specialist supervision:

• Advanced or metastatic non-small cell lung cancer (NSCLC) with documented sensitising EGFR mutations
• First-line targeted therapy in EGFR mutation–positive NSCLC where gefitinib is recommended by current guidelines
• Subsequent-line targeted therapy in selected patients whose disease remains suitable for EGFR inhibitor treatment

Your oncology team will determine whether Geftib 250 mg is appropriate based on mutation testing, prior treatments, performance status and co-morbidities.

How Gefitinib Works in Chemotherapy

Gefitinib is a targeted anticancer medicine from the class of EGFR tyrosine kinase inhibitors.
Unlike classic cytotoxic chemotherapy, Geftib gefitinib does not directly damage DNA.
Instead, it selectively blocks the intracellular tyrosine kinase domain of the epidermal growth factor receptor (EGFR).

In EGFR mutation–positive NSCLC, constitutively active EGFR triggers downstream signalling through pathways such as RAS/RAF/MEK/ERK and PI3K/AKT, promoting tumour cell survival and proliferation.
By binding to the ATP-binding site of the EGFR tyrosine kinase, Geftib 250 mg reduces receptor phosphorylation and interrupts these downstream signals.
This decreases proliferative and anti-apoptotic signalling, making tumour cells more likely to slow growth or undergo programmed cell death.

Because EGFR is also present in normal tissues, gefitinib therapy can lead to characteristic side effects such as skin rash and diarrhea, which require regular monitoring and supportive care.

Dosage & Administration

The dose and schedule of Geftib 250 mg must always follow your oncologist’s instructions.
In many protocols, the usual adult dose is one Geftib 250 mg tablet taken once daily, but only your treating team can confirm the correct regimen for you.

• Take Geftib tablets once daily at about the same time each day, with a glass of water.
• Swallow Geftib 250 mg whole; do not crush, split or chew the tablet unless your pharmacist provides specific instructions.
• Follow your clinic’s advice on taking gefitinib with or without food and try to be consistent with your routine.
• Do not change your daily dose, stop treatment or take extra tablets without clear guidance from your oncology team.
• If you miss a dose, follow the written instructions from your treatment centre; do not double the next dose unless your doctor specifically tells you to.

Regular clinic visits, blood tests and imaging will help your doctors assess response and decide whether your Geftib 250 mg gefitinib dose should continue or be adjusted.

Precautions

Before starting Geftib 250 mg gefitinib tablets, inform your healthcare team about your full medical history and all medicines, supplements and herbal products you use. Key precautions include:

• Pre-existing liver disease or abnormal liver function tests
• History of interstitial lung disease, chronic lung conditions or unexplained breathlessness
• Concurrent use of strong CYP3A4 inducers or inhibitors that may alter gefitinib levels
• Use of gastric acid–reducing medicines that can affect gefitinib tablet absorption
• Pregnancy or breastfeeding; Geftib gefitinib is not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use reliable contraception during and for a period after Geftib 250 mg therapy, as directed by their oncologist.

Gefitinib Side Effects

Common side effects

Common side effects of Geftib 250 mg gefitinib tablets include:

• Acne-like skin rash on the face and upper body
• Dry skin, itching or mild redness
• Diarrhea or loose stools
• Nausea, occasional vomiting or reduced appetite
• Mild mouth sores or oral irritation
• Fatigue or low energy
• Mild elevations in liver enzymes on blood tests

These effects are often manageable with supportive care, dermatologic treatments and, when necessary, dose adjustments as decided by your oncology team.

Serious side effects

Less common but serious side effects of gefitinib require urgent medical attention and may include:

• New or worsening shortness of breath, cough and fever suggesting interstitial lung disease or severe pneumonitis
• Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, persistent upper abdominal pain
• Severe or persistent diarrhea leading to dehydration
• Severe skin reactions, blistering or extensive rash
• Sudden chest pain or severe breathlessness

If you experience any of these symptoms while taking Geftib 250 mg, seek emergency medical care immediately and contact your oncology team.

Storage

• Store Geftib 250 mg gefitinib tablets at room temperature, preferably below 25 °C.
• Keep tablets in their original blisters and outer carton, protected from moisture and light.
• Keep all anticancer medicines out of the sight and reach of children and pets.
• Do not use Geftib after the expiry date printed on the packaging.

Ask your pharmacist how to safely dispose of unused or expired Geftib gefitinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart provides safe, structured access to key oncology medicines such as
Geftib 250 mg gefitinib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Geftib online from Generic Meds Mart, you benefit from:

• Original gefitinib 250 mg blisters and cartons from licensed suppliers
• Discreet, plain outer packaging for international delivery
• Tracked shipping options to many destinations
• Clear, structured information about Geftib gefitinib tablets to support discussions with your oncology team
• Support for ordering, payment and delivery questions

Order Now

Geftib 250 mg gefitinib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Geftib online, ensure your oncologist has confirmed an EGFR mutation–positive tumour, recommended gefitinib as part of your treatment plan and specified the daily dose and duration.

Select Geftib 250 mg (1 pack / 30 tablets), choose the quantity that matches your written plan, add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.